Diabetes News

Scientists may have found a new tool for studying—and maybe even treating—Type 2 diabetes.

The proportion of deaths attributable to diabetes in the U.S. is as high as 12%- three times higher than estimates based on death certificates suggest, according to a new analysis led by a Boston University School of Public Health (BUSPH) researcher.

Renal denervation improved the liver's sensitivity to insulin in a study of laboratory animals conducted at the Bergman Laboratory in the Diabetes and Obesity Research Institute at Cedars-Sinai.

As the leading cause of end-stage renal disease (ESRD),1 diabetes requires significant attention from the renal community to effectively prevent and manage it before it leads to ESRD, and also to manage diabetes as a comorbid condition of ESRD. The following three initiatives are program developed at DaVita Kidney Care and dedicated to continuously improving these efforts.

The U.S. Food and Drug Administration has approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

University of Illinois at Chicago researchers have received a five-year, $4 million federal grant to study how mobile technology can assist African American and Hispanic patients adhere to their diabetes treatment plans.

A new strategy developed by researchers from Fundacion Jimenez Diaz University Hospital-Health Research Institute at the Autonomous University of Madrid, may help halt the progression of kidney disease in patients with diabetes. The approach is highlighted in an article entitled, “Suppressor of cytokine signaling-1 (SOCS1) peptidomimetic limits progression of diabetic nephropathy,” published in the Journal of the American Society of Nephrology.

A team from the University of Montreal Hospital Research Centre (CRCHUM) has discovered a novel link between chronic kidney disease and diabetes.

Among U.S. adults with diabetes from 1988 to 2014, the overall prevalence of diabetic kidney disease did not change significantly, while the prevalence of albuminuria declined and the prevalence of reduced estimated glomerular filtration rate increased, according to a study appearing in the Aug. 9 issue of JAMA.

A new study of 2005-2014 National Health and Nutrition Examination Survey (NHANES) data has found that the prevalence of diabetes among U.S. adolescents is higher than previously reported.